The Cycle of EBV Infection Explains Persistence, the Sizes of the Infected Cell Populations and Which Come under CTL Regulation

PLoS Pathogens

Volumn 9, Issue 10, 2013, Pages

  Hawkins, Jared B ^a,d   Delgado Eckert, Edgar ^b   Thorley Lawson, David A ^a   Shapiro, Michael ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c TUFTS UNIVERSITY   (United States)

^d Harvard Medical School Center for Biomedical Informatics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN;

ANTIGENICITY; ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CELL POPULATION; CYTOTOXIC T LYMPHOCYTE; DYNAMICS; EPSTEIN BARR VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOREGULATION; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; NONHUMAN; OUTCOME ASSESSMENT; PARAMETERS; PREVALENCE; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM;

B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; EPSTEIN-BARR VIRUS INFECTIONS; GERMINAL CENTER; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNITY, CELLULAR; MODELS, IMMUNOLOGICAL;

EID: 84887303867     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003685     Document Type: Article

References (53)

1. Rickinson AB, Kieff E (2007) Epstein-Barr Virus. In: Knipe DM, Howley PM, editors. Virology. 5th ed. ed. New York: Lippincott Williams and Wilkins. pp. 2655-2700.
2. Thorley-Lawson DA, Gross A, (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350: 1328-1337.
3. Thorley-Lawson D (2005) EBV persistence and latent infection in vivo. In: ES R, editor. Epstein-Barr Virus. 1st ed. Norfolk, England: Caister Academic Press. pp. 309-349.
4. Thorley-Lawson DA, Allday MJ, (2008) The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat Rev Microbiol 6: 913-924.
5. Hadinoto V, Shapiro M, Sun CC, Thorley-Lawson DA, (2009) The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog 5: e1000496.
6. Khan G, Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA, (1996) Is EBV persistence in vivo a model for B cell homeostasis? Immunity 5: 173-179.
7. Hislop AD, Taylor GS, Sauce D, Rickinson AB, (2007) Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 25: 587-617.
8. Thorley-Lawson DA, (2001) Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 1: 75-82.
9. Kurth J, Hansmann ML, Rajewsky K, Kuppers R, (2003) Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction. Proc Natl Acad Sci U S A 100: 4730-4735.
10. Kurth J, Spieker T, Wustrow J, Strickler GJ, Hansmann LM, et al. (2000) EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. Immunity 13: 485-495.
11. Hochberg D, Middeldorp JM, Catalina M, Sullivan JL, Luzuriaga K, et al. (2004) Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci U S A 101: 239-244.
12. Kraus RJ, Mirocha SJ, Stephany HM, Puchalski JR, Mertz JE, (2001) Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus. J Virol 75: 867-877.
13. Laichalk LL, Thorley-Lawson DA, (2005) Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol 79: 1296-1307.
14. Kieff E, Rickinson AB (2007) Epstein-Barr Virus and Its Replication. In: Knipe DM, Howley PM, editors. Fields Virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins. pp. 2603-2654.
15. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA, (1998) EBV persistence in memory B cells in vivo. Immunity 9: 395-404.
16. Babcock GJ, Hochberg D, Thorley-Lawson AD, (2000) The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13: 497-506.
17. Roughan JE, Thorley-Lawson DA, (2009) The intersection of Epstein-Barr virus with the germinal center. J Virol 83: 3968-3976.
18. Siemer D, Kurth J, Lang S, Lehnerdt G, Stanelle J, et al. (2008) EBV transformation overrides gene expression patterns of B cell differentiation stages. Mol Immunol 45: 3133-3141.
19. Casola S, Otipoby KL, Alimzhanov M, Humme S, Uyttersprot N, et al. (2004) B cell receptor signal strength determines B cell fate. Nat Immunol 5: 317-327.
20. Castiglione F, Duca K, Jarrah A, Laubenbacher R, Hochberg D, et al. (2007) Simulating Epstein-Barr virus infection with C-ImmSim. Bioinformatics 23: 1371-1377.
21. Delgado-Eckert E, Shapiro M, (2011) A model of host response to a multi-stage pathogen. J Math Biol 63: 201-227.
22. Duca KA, Shapiro M, Delgado-Eckert E, Hadinoto V, Jarrah AS, et al. (2007) A virtual look at Epstein-Barr virus infection: biological interpretations. PLoS Pathog 3: 1388-1400.
23. Huynh G, Rong L, (2012) Modeling the dynamics of virus shedding into the saliva of Epstein-Barr virus positive individuals. J Theor Biol 310C: 105-114.
24. Huynh GT, Adler FR, (2011) Alternating host cell tropism shapes the persistence, evolution and coexistence of epstein-barr virus infections in human. Bull Math Biol 73: 1754-1773.
25. Huynh GT, Adler FR, (2011) Mathematical modelling the age dependence of Epstein-Barr virus associated infectious mononucleosis. Math Med Biol 29 (3):: 245-61.
26. Shapiro M, Duca KA, Lee K, Delgado-Eckert E, Hawkins J, et al. (2008) A virtual look at Epstein-Barr virus infection: simulation mechanism. J Theor Biol 252: 633-648.
27. Asquith B, Bangham CR, (2003) An introduction to lymphocyte and viral dynamics: the power and limitations of mathematical analysis. Proc Biol Sci 270: 1651-1657.
28. Nowak MA, May RM (2000) Virus dynamics: mathematical principles of immunology and virology. Oxford; New York: Oxford University Press. xii, 237 p. p.
29. Perelson AS, (2002) Modelling viral and immune system dynamics. Nat Rev Immunol 2: 28-36.
30. Perelson AS, Nelson PW, (1999) Mathematical Analysis of HIV-1 Dynamics in Vivo. SIAM Rev 41: 3-44.
31. Wodarz D (2007) Killer cell dynamics: mathematical and computational approaches to immunology. New York, NY: Springer. xiii, 220 p. p.
32. Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, et al. (1992) Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J Exp Med 176: 157-168.
33. Pudney VA, Leese AM, Rickinson AB, Hislop AD, (2005) CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells. J Exp Med 201: 349-360.
34. Allen CD, Okada T, Cyster JG, (2007) Germinal-center organization and cellular dynamics. Immunity 27: 190-202.
35. Hislop AD, Kuo M, Drake-Lee AB, Akbar AN, Bergler W, et al. (2005) Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance. J Clin Invest 115: 2546-2555.
36. Boyaka PN, Wright PF, Marinaro M, Kiyono H, Johnson JE, et al. (2000) Human nasopharyngeal-associated lymphoreticular tissues. Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils. Am J Pathol 157: 2023-2035.
37. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, et al. (1995) Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375: 685-688.
38. Apcher S, Daskalogianni C, Manoury B, Fahraeus R, (2010) Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation. PLoS Pathog 6: e1001151.
39. Yin Y, Manoury B, Fahraeus R, (2003) Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science 301: 1371-1374.
40. Box GEP, Draper NR (1987). Empirical Model Building and Response Surfaces. ew York, NY: John Wiley & Sons.
41. Laichalk LL, Hochberg D, Babcock GJ, Freeman RB, Thorley-Lawson DA, (2002) The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity 16: 745-754.
42. Vezina HE, Balfour HH Jr, Weller DR, Anderson BJ, Brundage RC, (2010) Valacyclovir pharmacokinetics and exploratory pharmacodynamics in young adults with Epstein-Barr virus infectious mononucleosis. J Clin Pharmacol 50: 734-742.
43. Gershburg E, Pagano JS, (2005) Epstein-Barr virus infections: prospects for treatment. J Antimicrob Chemother 56: 277-281.
44. Nowak MA, Bangham CR, (1996) Population dynamics of immune responses to persistent viruses. Science 272: 74-79.
45. Donati D, Zhang LP, Chene A, Chen Q, Flick K, et al. (2004) Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect Immun 72: 5412-5418.
46. Moormann AM, Chelimo K, Sumba PO, Tisch DJ, Rochford R, et al. (2007) Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children. J Infect Dis 195: 799-808.
47. Turk SM, Jiang R, Chesnokova LS, Hutt-Fletcher LM, (2006) Antibodies to gp350/220 enhance the ability of Epstein-Barr virus to infect epithelial cells. J Virol 80: 9628-9633.
48. MacLennan IC, (1998) B-cell receptor regulation of peripheral B cells. Curr Opin Immunol 10: 220-225.
49. Sallusto F, Geginat J, Lanzavecchia A, (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22: 745-763.
50. Surh CD, Sprent J, (2008) Homeostasis of naive and memory T cells. Immunity 29: 848-862.
51. Veiga-Fernandes H, Walter U, Bourgeois C, McLean A, Rocha B, (2000) Response of naive and memory CD8+ T cells to antigen stimulation in vivo. Nat Immunol 1: 47-53.
52. Shapiro M, Delgado-Eckert E (2013) Saturation effects on T-cell activation in a model of a multi-stage pathogen. BIOMAT 2012: International Symposium on Mathematical and Computational Biology: World Scientific.
53. Hadinoto V, Shapiro M, Greenough TC, Sullivan JL, Luzuriaga K, et al. (2008) On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood 111: 1420-1427.